Tag: risk-based monitoring IRB oversight

Missing IRB Meeting Minutes in TMF Audit Findings

Posted on digi By digi

Missing IRB Meeting Minutes in TMF Audit Findings Why Missing IRB Meeting Minutes Are a Recurring Audit Finding in TMFs Introduction: The Importance of IRB Meeting Documentation Institutional Review Board (IRB) or Ethics Committee (EC) meeting minutes are critical documents that demonstrate ethical oversight, review of study protocols, and decision-making processes. Regulatory agencies including the…

Read More “Missing IRB Meeting Minutes in TMF Audit Findings” »

Ethics Committee / IRB Audit Findings, Regulatory Audit Findings

IRB Oversight Failures in Multicenter Clinical Trials

Posted on digi By digi

IRB Oversight Failures in Multicenter Clinical Trials Why IRB Oversight Failures Are Common in Multicenter Clinical Trials Introduction: The Challenges of Multicenter IRB Oversight Multicenter clinical trials involve multiple investigator sites across regions or countries, increasing complexity in regulatory oversight and ethical review. Institutional Review Boards (IRBs) or Ethics Committees (ECs) are responsible for ensuring…

Read More “IRB Oversight Failures in Multicenter Clinical Trials” »

Ethics Committee / IRB Audit Findings, Regulatory Audit Findings

IRB Audit Findings: Common Issues in Clinical Trials

Posted on digi By digi

IRB Audit Findings: Common Issues in Clinical Trials Understanding Common IRB Audit Findings in Clinical Trials Introduction: The Role of IRBs in Clinical Trials Institutional Review Boards (IRBs) or Ethics Committees (ECs) play a critical role in protecting the rights, safety, and welfare of participants in clinical trials. Regulatory agencies such as the FDA, EMA,…

Read More “IRB Audit Findings: Common Issues in Clinical Trials” »

Ethics Committee / IRB Audit Findings, Regulatory Audit Findings